Dr. del Cid will treat patients at the Retina Group’s Plantation, Hollywood, Fort Lauderdale and Boca Raton offices.
Dr. del Cid received his MD from Tulane University, according to his bio. He then completed an ophthalmology residency from University of Texas Health Science Center in San Antonio and a fellowship in vitreoretinal disease and surgery with the Cincinnati Eye Institute at the University of Cincinnati.
Dr. del Cid has a research interest in the use of non-steroidal therapeutics in ophthalmology.
Related Articles on Ophthalmologists:
40 Ophthalmology-Driven Surgery Centers to Know
Ophthalmologist Dr. Allen Beck Appointed to Childhood Glaucoma Research Network Exec Committee
Ophthalmologist Steven E. Feldon Named to NIH Study Section
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
